Advanced Liquid Biopsies for Prostate Cancer
The next generation of liquid biopsies: Predictive and pharmacologic biomarkers
['FUNDING_OTHER'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-11167777
This project is creating new blood tests to help guide treatment for men with prostate cancer that has become resistant to current therapies.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-11167777 on ClinicalTrials.gov |
What this research studies
Our team is working to find better ways to treat prostate cancer that no longer responds to standard treatments. We are developing advanced blood tests, called liquid biopsies, to detect specific changes in cancer cells that can help doctors choose the most effective precision medicine. These tests aim to identify why some cancers become resistant and to discover new weaknesses in the cancer that can be targeted with new therapies. The goal is to bring these new discoveries and tests into clinical trials to directly benefit patients.
Who could benefit from this research
Good fit: This research is most relevant for men with prostate cancer, especially those whose cancer has become resistant to current treatments.
Not a fit: Patients without prostate cancer or those whose cancer is not yet resistant to treatment may not directly benefit from this specific research focus.
Why it matters
Potential benefit: If successful, this work could lead to more personalized and effective treatments for men with advanced prostate cancer, helping doctors choose the right therapy at the right time.
How similar studies have performed: While liquid biopsies are an emerging field, previous work by this team has successfully identified genomic alterations in prostate cancer using similar approaches, and these findings are being translated into clinical trials.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SPERGER, JAMIE M — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: SPERGER, JAMIE M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers